German COVID-19 vaccine maker Biotech, partner of U.S. pharmaceutical group Pfizer , said on Monday it aims to produce two billion doses of its vaccine this year.
“We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated 6-dose label,” Biotech said in a presentation. — Reuters
Leave a Reply